Treatment with a novel hexavalent OX40 agonist enhances activation of circulating T cells to favor anti-tumor immunity
Publication Title
SITC Annual Meeting; November 6-10; Houston, TX. 2024;12(Suppl 2): 1301
Document Type
Abstract
Publication Date
11-1-2024
Keywords
oregon; chiles
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Comments
Holay N, Kasiewicz MJ, Yadav R, Rolig AS, Diaz-De-Durana Y, Redmond WL